TROG Cancer Research - Home

- trog.com.au

As one of the largest cancer clinical trials groups in Australia/New Zealand, TROG Cancer Research conducts world-class research involing radiotherapy to improve outcomes and quality of life for people affected by cancer.

7,960,297 $ 8.95


STARTRK-2 Clinical Study for Advanced Cancers | Check for NTRK

- ignytastartrktrials.com

STARTRK-2 is a clinical trial studying entrectinib as a therapy for cancers with the NTRK, ROS1, or ALK cancer causing mutations. Check For NTRK today.

Not Applicable $ 8.95


STARTRK-2 Clinical Study for Advanced Cancers | Check for NTRK

- rxdxstartrktrials.com

STARTRK-2 is a clinical trial studying entrectinib as a therapy for cancers with the NTRK, ROS1, or ALK cancer causing mutations. Check For NTRK today.

Not Applicable $ 8.95